On Feb 7, 2022 Endeavor BioMedicines closed a Series B round and raised $101,000,000 from Ally Bridge Group, Avidity Partners, Longitude Capital, Omega Funds, Perceptive […]
Series A – 1859
On Feb 7, 2022 1859 closed a Series A round and raised $40,000,000 from FusionX Ventures, Northpond Ventures, OMX Ventures, Vertical Venture Partners, featuring lead […]
Series B – Koya Medical
On Feb 3, 2022 Koya Medical closed a Series B round and raised $26,000,000 from 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital, Cadence […]
Seed Round – Nostos Genomics
On Feb 3, 2022 Nostos Genomics closed a Seed round and raised €5,000,000 from 42CAP, Amino Collective, Entrepreneur First, Frontline Ventures, featuring lead investors . […]
Series C – Dewpoint Therapeutics
On Feb 3, 2022 Dewpoint Therapeutics closed a Series C round and raised $150,000,000 from 3E Bioventures, ARCH Venture Partners, EcoR1 Capital, General Catalyst, Leaps […]
Series B – Koya Medical
On Feb 3, 2022 Koya Medical closed a Series B round and raised $26,000,000 from 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital, Cadence […]
Series A – Biofidelity
On Feb 1, 2022 Biofidelity closed a Series A round and raised $23,000,000 from Octopus Ventures, SBI Investment, featuring lead investors Octopus Ventures. About the […]
Venture Round – Phylos
On Feb 1, 2022 Phylos closed a Venture – Series Unknown round and raised $7,600,000 from Accomplice, Entourage Effect Capital, Merida Capital Holdings, featuring lead […]
Post-IPO Debt – IntelGenX
On Feb 1, 2022 IntelGenX closed a Post-IPO Debt round and raised $3,000,000 from ATAI Life Sciences, featuring lead investors ATAI Life Sciences. About the […]
Post-IPO Debt – Centogene
On Feb 1, 2022 Centogene closed a Post-IPO Debt round and raised $45,000,000 from Oxford Finance LLC, featuring lead investors Oxford Finance LLC. About the […]
